Enova International grants 6,190 options to chair

Enova International, Inc.'s Executive Chairman David Fisher received a grant of 6,190 non-qualified stock options on August 5, 2026, with an exercise price of $257.79 per share and expiration on August 5, 2033.

Rhea-AI Filing Summary

Enova International, Inc.'s Executive Chairman David Fisher received a grant of 6,190 non-qualified stock options on August 5, 2026, with an exercise price of $257.79 per share and expiration on August 5, 2033. The options vest in three equal annual installments from 2027 to 2029 and are paired with a limited stock appreciation right exercisable only upon a qualifying change in control and offer, as defined in the grant agreement.

Insider Trade Summary

Grant/Award: 6,190 shares

Grant/Award 1 txn

Insider Fisher David

Role Executive Chairman

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy) with limited SAR F1, F2, F3	6,190	$0.00	$0.00

Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 6,190 contracts (Direct)

Footnotes (3)

1. F1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
2. F2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
3. F3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

Key Figures

Options granted: 6,190 shares Exercise price: $257.79 per share Expiration date: August 5, 2033 +2 more

5 metrics

Options granted 6,190 shares Non-qualified stock options with limited SAR granted to David Fisher on August 5, 2026

Exercise price $257.79 per share Exercise price of non-qualified stock options granted to David Fisher

Expiration date August 5, 2033 Expiration of the non-qualified stock options granted on August 5, 2026

Vesting schedule One-third on August 5, 2027; August 5, 2028; August 5, 2029 Vesting of the 6,190 stock options, contingent on continued employment

Derivative holdings after grant 6,190 options Total derivative securities held directly by David Fisher following this grant

Key Terms

Non-Qualified Stock Option, stock appreciation right, Change in Control, tender offer

4 terms

Non-Qualified Stock Option financial

"Security titled "Non-Qualified Stock Option (right to buy) with limited SAR""

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

stock appreciation right financial

"The limited stock appreciation right ("SAR") and employee stock option were granted"

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

Change in Control financial

"may be exercised only during the period following the date that a "Change in Control""

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

tender offer financial

""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"

A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Enova (ENVA) report for Executive Chairman David Fisher?

Enova reported that Executive Chairman David Fisher received a grant of 6,190 non-qualified stock options on August 5, 2026. These options carry an exercise price of $257.79 per share and expire on August 5, 2033, forming part of his equity-based compensation.

How many Enova (ENVA) options does David Fisher hold after this reported grant?

After the reported transaction, David Fisher holds 6,190 non-qualified stock options directly. These options are tied to Enova common stock and represent derivative securities that can be exercised at $257.79 per share before their August 5, 2033 expiration, subject to vesting conditions.

What are the exercise price and expiration date of David Fisher’s new Enova (ENVA) options?

David Fisher’s newly granted options have an exercise price of $257.79 per share and an expiration date of August 5, 2033. They are structured as non-qualified stock options on Enova common stock, granted as part of his role as Executive Chairman.

When do David Fisher’s newly granted Enova (ENVA) stock options vest?

The options vest in three substantially equal one-third installments on August 5, 2027, August 5, 2028 and August 5, 2029. Vesting requires that Fisher continues to serve as an employee of Enova or an affiliate through each applicable vesting date, according to the grant terms.

What special stock appreciation right (SAR) terms are attached to David Fisher’s Enova (ENVA) options?

The grant includes a limited stock appreciation right (SAR) issued in tandem with the option. The SAR is exercisable only after a defined change in control and for 30 days, paying the excess of “Offer Value Per Share” over the option exercise price, only if a qualifying offer occurs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:31 PM Accepted by SEC EDGAR 08/07/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher David

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO ILLINOIS 60604

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(1)(2)	$257.79	08/05/2026		A		6,190		(3)	08/05/2033	Common stock; par value $0.00001 per share	6,190	$0	6,190	D

Explanation of Responses:

1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: August 5, 2027, August 5, 2028 and August 5, 2029.

	/s/ Sean Rahilly, as attorney in fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)